Table 3.
The distribution of low and high grade of soft tissue pathologies among study groups.
| Study groups |
|||||||||
|---|---|---|---|---|---|---|---|---|---|
| A (n =10) | B (n =10) | p | A (n =10) | C (n =10) | p | B (n =10) | C (n =10) | p | |
| STP-1 | |||||||||
| Edema | |||||||||
| LG | 8 | 4 | 0.085 | 8 | 2 | 0.012* | 4 | 2 | 0.314 |
| HG | 2 | 6 | 2 | 8 | 6 | 8 | |||
| Inflammation | |||||||||
| LG | 2 | 6 | 0.085 | 2 | 2 | 0.709 | 4 | 2 | 0.085 |
| HG | 8 | 4 | 8 | 8 | 6 | 8 | |||
| Endothelial proliferation | |||||||||
| LG | 10 | 6 | 0.043* | 10 | 4 | 0.005* | 6 | 4 | 0.371 |
| HG | – | 4 | – | 6 | 4 | 6 | |||
| Necrosis | |||||||||
| LG | 9 | 7 | 0.291 | 9 | 2 | 0.003* | 7 | 2 | 0.035* |
| HG | 1 | 3 | 1 | 8 | 3 | 8 | |||
| STP-2 | |||||||||
| Muscle atrophy and deformation | |||||||||
| LG | 9 | 4 | 0.029* | 9 | – | 0.000* | 4 | – | 0.043* |
| HG | 1 | 6 | 1 | 10 | 6 | 10 | |||
| Calcification | |||||||||
| LG | 6 | 4 | 0.328 | 6 | 2 | 0.085 | 4 | 2 | 0.314 |
| HG | 4 | 6 | 4 | 8 | 6 | 8 | |||
| Vascular hyalinization | |||||||||
| LG | 10 | 10 | – | 10 | 6 | 0.043* | 10 | 6 | 0.043* |
| HG | – | – | – | 4 | – | 4 | |||
| Fibrosis | |||||||||
| LG | 7 | 7 | 0.686 | 7 | 2 | 0.035* | 7 | 2 | 0.035* |
| HG | 3 | 3 | 3 | 8 | 3 | 8 | |||
STP: soft tissue pathologies; group A: control arm; group B: fractionated HDR arm; group C: single fractionated HDR arm; LG: low grade; HG: high grade.
*
p ≤ 0.05, as statistically significant.